Clinical Trial Update: Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) [Phase 1]

View source ↗

Summary

A Phase 1 trial (ARYA-1) evaluating ET140203 T Cells in adults with advanced hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ET140203 T cells

Snippet

Sponsor: Eureka Therapeutics Inc. | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 1 | Status: TERMINATED